Atorvastatin Calcium
Product Images NDC 68071-2964

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2964 9)

Atorvastatin Calcium 80 mg tablets bottle label by NuCare Pharmaceuticals, Inc. The label indicates a package size of 90 tablets, prescription only (Rx Only). It includes NDC 68071-2964-9, product number R1608090, and manufacturing details by Granules Pharmaceuticals Pvt. Ltd., India. The label advises to see manufacturer's label for full ingredient list and storage instructions at controlled temperature 68-77°F.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Chemical structure diagram of atorvastatin calcium showing its molecular elements and arrangement, including calcium and water components as indicated by Ca2+ and 3H2O.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

A cumulative incidence line graph comparing Atorvastatin and Placebo groups over a period of 3.5 years. The x-axis represents years, and the y-axis shows cumulative incidence as a percentage. The graph includes hazard ratio and p-value statistics for comparison between the groups.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

A line graph comparing the cumulative hazard percentage over up to five years of follow-up for placebo versus atorvastatin. The graph plots time to first primary endpoint, showing lower cumulative hazard for atorvastatin compared to placebo, with a hazard ratio and significance indicated on the chart.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

A line graph showing the percentage of subjects experiencing an event over time in years. It compares atorvastatin 10 mg and atorvastatin 80 mg in relation to the time to the first major cardiovascular endpoint, with hazard ratio and p-value noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.